| Application no. and date | 02012942.5 (espacenet) (Federated) (European Patent Register), 19970724 | | Patent/reg. no. and date | DK/EP 1285916, 20100310 | | Publication date | 20030226 | | Priority no. and date | US 690258, 19960724, US 701494, 19960822, US 48278 P, 19970530 | | EP pub. no. and date |
EP 1285916 20030226 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 7 Powder Horn Drive
Warren
New Jersey 07059, US | | Applicant ref. no. | P34303dk03 | | Inventor | Stirling, David I., 3281 Round Hill Road,
Branchburg, NJ 08876, US,
Chen, Roger, Shen-Chu, 110 Christie Street,
Edison, NJ 08820, US,
MULLER, George, W., P.O. Box 3688
Rancho Santa Fe,
CA 92067, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , C07D 401/04 (2006.01) | | Title | Substituerede 2-(2,6-dioxopiperidin-3-yl)-phthalimider og -1-oxoiso-indoliner og fremgangsmåde til fremstilling af TNF-alfa-niveauer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
